Is renin-angiotensin system blockade helpful or harmful in COVID-19?
Leading cardiologists are leaning on the side of keeping patients on their antihypertensives
Far from renin-angiotensin system blockers putting patients at greater danger from COVID-19, recent research now suggests the drugs might even confer some benefit.
The knowledge that the SARS-CoV-2 virus uses its infamous ‘spike protein’ to enter cells via their ACE2 receptors has led to concern that patients on ACE inhibitors or ARBs might be more susceptible to infection.
